Literature DB >> 12931558

A modified ultrasensitive assay to detect quantified HIV-1 RNA of fewer than 50 copies per milliliter.

Estelle M Piwowar-Manning1, Terry A Henderson, Lorraine Brisbin, J Brooks Jackson.   

Abstract

We compared the sensitivity and specificity of versions 1.0 and 1.5 and a modified version 1.5 of the AMPLICOR HIV-1 MONITOR ultrasensitive RNA assay (Roche, Indianapolis, IN) by using a virus stock dilution series and plasma samples from HIV-1-infected and uninfected subjects. The modified assay was linear and consistently positive down to 12 copies per milliliter vs 25 copies per milliliter for the other 2 assays. Versions 1.0, 1.5, and modified 1.5, respectively, detected 9 (23%) of 39, 11 (28%) of 40, and 43 (61%) of 71 replicates of a 4-copy-number and 11 (28%) of 40, 17 (46%) of 37, and 88 (90%) of 98 replicates of a 10-copy-number standard. Of 44 patient samples with undetectable levels using version 1.0, 32 (73%) had detectable levels on the modified assay, and 5 (25%) of 20 had detectable levels on version 1.5. None of the assays detected HIV-1 RNA in HIV-1 antibody-negative samples. The modified version 1.5 of the RNA assay is more sensitive for detecting HIV-1 RNA in significantly more patients than are versions 1.0 and 1.5.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12931558     DOI: 10.1309/TRRQ-FWM9-LE9H-427M

Source DB:  PubMed          Journal:  Am J Clin Pathol        ISSN: 0002-9173            Impact factor:   2.493


  5 in total

1.  Identification of ongoing human immunodeficiency virus type 1 (HIV-1) replication in residual viremia during recombinant HIV-1 poxvirus immunizations in patients with clinically undetectable viral loads on durable suppressive highly active antiretroviral therapy.

Authors:  Carlum Shiu; Coleen K Cunningham; Thomas Greenough; Petronella Muresan; Victor Sanchez-Merino; Vincent Carey; J Brooks Jackson; Carrie Ziemniak; Lawrence Fox; Marvin Belzer; Stuart C Ray; Katherine Luzuriaga; Deborah Persaud
Journal:  J Virol       Date:  2009-07-15       Impact factor: 5.103

Review 2.  Immune restoration after antiretroviral therapy: the pitfalls of hasty or incomplete repairs.

Authors:  Eleanor M P Wilson; Irini Sereti
Journal:  Immunol Rev       Date:  2013-07       Impact factor: 12.988

3.  Increased sensitivity of the Roche COBAS AMPLICOR HCV test, version 2.0, using modified extraction techniques.

Authors:  Michael Stuart Forman; Alexandra Valsamakis
Journal:  J Mol Diagn       Date:  2004-08       Impact factor: 5.568

4.  Comparison of versions 1.0 AND 1.5 of the UltraSensitive AMPLICOR HIV-1 MONITOR test for subjects with low viral load.

Authors:  J Brooks Jackson; Estelle Piwowar-Manning; LeTanya Johnson-Lewis; Roland Bassett; Lisa M Demeter; Donald Brambilla
Journal:  J Clin Microbiol       Date:  2004-06       Impact factor: 5.948

5.  Transient detectable viremia and the risk of viral rebound in patients from the Swiss HIV Cohort Study.

Authors:  Jim Young; Martin Rickenbach; Alexandra Calmy; Enos Bernasconi; Cornelia Staehelin; Patrick Schmid; Matthias Cavassini; Manuel Battegay; Huldrych F Günthard; Heiner C Bucher
Journal:  BMC Infect Dis       Date:  2015-09-21       Impact factor: 3.090

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.